TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL BIOIMPEDANCE ANALYZERS MARKET, BY TYPE
6.1. Overview
6.2. Multi-Frequency
6.3. Single-Frequency
6.4. Dual-Frequency
7. GLOBAL BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY
7.1. Overview
7.2. Wired Bioimpedance
7.3. Wireless Bioimpedance
8. GLOBAL BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION
8.1. Overview
8.2. Whole-Body Measurement
8.3. Segmental Body Measurement
9. GLOBAL BIOIMPEDANCE ANALYZERS MARKET, BY END USER
9.1. Overview
9.2. Hospitals
9.3. Fitness Clubs and Wellness Centers
9.4. Home Users
9.5. Others
10. GLOBAL BIOIMPEDANCE ANALYZERS MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Bioimpedance Analyzers Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Bioimpedance Analyzers Market,
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. COMPANY PROFILES
12.1. Bioparhom
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Akern
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Biodynamics Corporation
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Tanita Corporation
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Biotekna
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Omron Corporation
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. InBody
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. EVOLT 360
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. RJL Systems
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Fook Tin Group Holding Ltd
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, SYNOPSIS, 2019–2030
TABLE 2 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, ESTIMATES & FORECAST, 2019–2030 (USD MILLION)
TABLE 3 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 4 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 5 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 6 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 7 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 8 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 9 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 10 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 11 US: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 12 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 13 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 14 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 15 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 16 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 17 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 18 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 1 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 2 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 3 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 4 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 5 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 6 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 7 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 8 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 9 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 10 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 11 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 12 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 13 ITALY: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 14 ITALY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 15 ITALY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 16 ITALY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 17 SPAIN: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 18 SPAIN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 19 SPAIN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 20 SPAIN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 21 UK: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 22 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 23 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 24 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END UER, 2019–2030 (USD MILLION)
TABLE 25 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 26 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 27 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 28 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 33 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 34 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 35 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 36 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 37 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 38 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 39 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 40 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 41 INDIA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 42 INDIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 43 INDIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 44 INDIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 45 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 46 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 47 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 48 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 49 SOUTH KOREA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 50 SOUTH KOREA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 51 SOUTH KOREA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 52 SOUTH KOREA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 53 REST OF ASIA-PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 54 REST OF ASIA-PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 55 REST OF ASIA-PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 56 REST OF ASIA-PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 57 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 58 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 59 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 60 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 61 MIDDLE EAST: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 62 MIDDLE EAST: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 63 MIDDLE EAST: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 64 MIDDLE EAST: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 65 AFRICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 66 AFRICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 67 AFRICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 68 AFRICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
TABLE 69 LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY TYPE, 2019–2030 (USD MILLION)
TABLE 70 LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2019–2030 (USD MILLION)
TABLE 71 LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 72 LATIN AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2019–2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BIOIMPEDANCE ANALYZERS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BIOIMPEDANCE ANALYZERS MARKET
FIGURE 4 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, SHARE (%), BY TYPE, 2021
FIGURE 5 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, SHARE (%), BY MODALITY, 2021
FIGURE 6 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, SHARE (%), BY APPLICATION, 2021
FIGURE 7 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, SHARE (%), BY END USER, 2021
FIGURE 8 GLOBAL BIOIMPEDANCE ANALYZERS MARKET, SHARE (%), BY REGION, 2021
FIGURE 9 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, SHARE (%), BY REGION, 2021
FIGURE 10 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, SHARE (%), BY REGION, 2021
FIGURE 11 ASIA-PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, SHARE (%), BY REGION, 2021
FIGURE 12 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, SHARE (%), BY REGION, 2021
FIGURE 13 GLOBAL BIOIMPEDANCE ANALYZERS MARKET: COMPANY SHARE ANALYSIS, 2021 (%)
FIGURE 14 BIOPARHOM: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 BIOPARHOM: SWOT ANALYSIS
FIGURE 16 AKERN: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 AKERN: SWOT ANALYSIS
FIGURE 18 BIODYNAMICS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 BIODYNAMICS CORPORATION: SWOT ANALYSIS
FIGURE 20 TANITA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 TANITA CORPORATION: SWOT ANALYSIS
FIGURE 22 BIOTEKNA.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 BIOTEKNA.: SWOT ANALYSIS
FIGURE 24 OMRON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 OMRON CORPORATION: SWOT ANALYSIS
FIGURE 26 INBODY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 INBODY: SWOT ANALYSIS
FIGURE 28 EVOLT 360: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 EVOLT 360: SWOT ANALYSIS
FIGURE 30 RJL SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 RJL SYSTEMS: SWOT ANALYSIS
FIGURE 32 FOOK TIN GROUP HOLDING LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 FOOK TIN GROUP HOLDING LTD: SWOT ANALYSIS
